Human lymphocytic B-leukemia cell line treatment with the bacterial toxin listeriolysin O and rituximab (anti-CD20 antibody): Effects of similar localization of their receptors. [electronic resource]
Producer: 20170403Description: 329-40 p. digitalISSN:- 0394-6320
- Antibodies, Monoclonal -- pharmacology
- Antigens, CD20 -- metabolism
- B-Lymphocytes -- drug effects
- Bacterial Toxins -- pharmacology
- Cell Line, Tumor
- Complement System Proteins -- metabolism
- Heat-Shock Proteins -- pharmacology
- Hemolysin Proteins -- pharmacology
- Humans
- Immunosuppressive Agents -- pharmacology
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Rituximab -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.